Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -99.97%86 | -2.96%-16.83K | 87.53%-6.67K | 29.77%-65.59K | -456.16%-329.05K | 2,154.56%333.29K | -287.58%-16.34K | 7.34%-53.48K | 72.60%-93.38K | -347.58%-59.17K |
| Net income from continuing operations | -21.62%-182.05K | 28.83%-170.47K | 37.44%-198.79K | -110.37%-746.06K | 76.54%-39.11K | -101.90%-149.69K | 2.61%-239.53K | -27.41%-317.74K | 591.84%7.2M | 48.70%-166.7K |
| Operating gains losses | -89.63%35.35K | -29.39%70K | -55.77%70.52K | 104.47%363.81K | -3,242.56%-235.52K | 104.20%340.76K | 427.08%99.14K | 14,046.05%159.43K | -22,595.27%-8.14M | 66.95%-7.05K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -29.65%25.47K | --0 |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | --42.25K | 1,763.76%359.17K | -153.60%-48.87K | --0 | --0 |
| Remuneration paid in stock | -66.72%432 | -66.74%427 | -67.06%423 | -79.20%4.3K | 122.63%432 | -74.50%1.3K | -84.75%1.28K | -85.83%1.28K | -87.56%20.67K | 72.06%-1.91K |
| Other non cashItems | 100.81%2.52K | 92.12%-961 | 76.67%-4.67K | -236.30%-253.06K | 2,139.68%90.08K | -612.36%-310.92K | -115.51%-12.19K | -147.29%-20.03K | -11.06%185.67K | -91.54%4.02K |
| Change In working capital | -5.27%143.83K | -37.63%84.17K | 1.84%125.85K | -8.59%565.43K | 37.87%155.06K | -21.92%151.84K | -31.83%134.95K | 8.74%123.58K | -17.22%618.54K | -61.65%112.47K |
| -Change in receivables | -97.16%1.08K | 409.76%4.32K | 150.87%4.57K | -34.21%25.21K | 38.32%-2.36K | -28.15%37.95K | -255.30%-1.39K | 22.34%-8.99K | 770.90%38.32K | -216.75%-3.82K |
| -Change in prepaid assets | 62.28%-1.16K | -345.76%-3.31K | -150.37%-1.43K | 94.88%-445 | 106.24%542 | -25,591.67%-3.08K | -5,407.14%-743 | 71,075.00%2.84K | 78.62%-8.68K | -990.70%-8.68K |
| -Change in payables and accrued expense | 23.03%143.92K | -39.33%83.17K | -5.41%122.71K | -8.19%540.67K | 25.53%156.87K | -17.43%116.98K | -30.43%137.09K | 3.59%129.73K | -25.79%588.91K | -57.68%124.97K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -99.74%86 | -2.96%-16.83K | 87.53%-6.67K | 29.77%-65.59K | 50.90%-29.05K | 125.20%33.29K | -287.58%-16.34K | 7.34%-53.48K | 72.60%-93.38K | -347.58%-59.17K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -76.88%-16.78K | -573.38%-12.8K | -130.30%-11.65K | -45.61%29.96K | -92.62%2.89K | -417.12%-9.48K | 96.71%-1.9K | -49.09%38.46K | 140.86%55.08K | 148.44%39.12K |
| Capital expenditure reported | -76.88%-16.78K | 1.52%-12.8K | -443.82%-11.65K | 72.29%-23.26K | -95.96%1.37K | 31.62%-9.48K | 81.67%-13K | 93.50%-2.14K | 22.01%-83.94K | 469.20%33.81K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---4.87K |
| Net investment purchase and sale | --0 | --0 | --0 | -61.72%53.22K | -85.05%1.52K | --0 | -15.70%11.1K | -62.58%40.6K | 611.57%139.02K | 114.21%10.17K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -76.88%-16.78K | -573.38%-12.8K | -130.30%-11.65K | -45.61%29.96K | -92.62%2.89K | -417.12%-9.48K | 96.71%-1.9K | -49.09%38.46K | 140.86%55.08K | 148.44%39.12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 145.00%49K | 66.67%25K | 19.99K | -2.03M | 2.01M | 20K | 15K | 0 | 0 |
| Net issuance payments of debt | --0 | 145.00%49K | 66.67%25K | --19.99K | ---2.03M | --2.01M | --20K | --15K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 145.00%49K | 66.67%25K | --19.99K | ---25.01K | --10K | --20K | --15K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 41.57%29.55K | -46.76%10.18K | -81.70%3.5K | -66.68%19.14K | 39.53%54.68K | -20.45%20.87K | -74.60%19.12K | -66.68%19.14K | -87.46%57.45K | -0.33%39.19K |
| Current changes in cash | -149.37%-16.69K | 1,003.19%19.37K | 25,773.08%6.68K | 59.17%-15.64K | -155.31%-51.18K | 161.10%33.81K | 103.58%1.76K | -100.15%-26 | 90.44%-38.31K | -210.54%-20.05K |
| End cash Position | -76.48%12.86K | 41.57%29.55K | -46.76%10.18K | -81.70%3.5K | -81.70%3.5K | 39.53%54.68K | -20.45%20.87K | -74.60%19.12K | -66.68%19.14K | -66.68%19.14K |
| Free cash from | -170.10%-16.69K | -0.97%-29.63K | 67.06%-18.33K | 49.90%-88.85K | -9.20%-27.69K | 2,504.70%23.81K | 52.82%-29.34K | 38.66%-55.62K | 60.46%-177.32K | -272.02%-25.35K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.